0001615219-20-000106.txt : 20201105 0001615219-20-000106.hdr.sgml : 20201105 20201105174403 ACCESSION NUMBER: 0001615219-20-000106 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201103 FILED AS OF DATE: 20201105 DATE AS OF CHANGE: 20201105 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Arthur David J. CENTRAL INDEX KEY: 0001769331 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36812 FILM NUMBER: 201291742 MAIL ADDRESS: STREET 1: 2450 HOLCOME BLVD. STREET 2: SUITE J-608 CITY: HOUSTON STATE: TX ZIP: 77021 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Salarius Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001615219 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 465087339 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2450 HOLCOMBE BLVD STREET 2: SUITE J-608 CITY: HOUSTON STATE: TX ZIP: 77021 BUSINESS PHONE: 346-772-0346 MAIL ADDRESS: STREET 1: 2450 HOLCOMBE BLVD STREET 2: SUITE J-608 CITY: HOUSTON STATE: TX ZIP: 77021 FORMER COMPANY: FORMER CONFORMED NAME: Flex Pharma, Inc. DATE OF NAME CHANGE: 20140730 4 1 wf-form4_160461622928134.xml FORM 4 X0306 4 2020-11-03 0 0001615219 Salarius Pharmaceuticals, Inc. SLRX 0001769331 Arthur David J. C/O SALARIUS PHARMACEUTICALS, INC. 2450 HOLCOME BLVD., SUITE X HOUSTON TX 77021 1 1 0 0 Chief Executive Officer Common Stock 2020-11-03 4 A 0 4879 0.561 A 86425 D The reporting person voluntarily agreed to receive a percentage of his base salary in issuer shares and receive these shares in lieu of net cash compensation. Shares are purchased at a price determined pursuant to the issuer's Employee Stock Purchase Plan. /s/Mark Rosenblum, as Attorney-in-Fact 2020-11-05